Pharmaceutical Commerce - March/April 2014

New reasons why the announced death of this profession will always be premature

What you need to know about the current specialty pharmacy landscape

Things to know about the increasingly popular--and competitive--orphan drug space

Facility will produce both biologics and small molecules

Getting to the 'future state' in cloud computing

Diving for customer insights through an ocean of crowdsourced data

Today's cloud-based, fast-evolving CRM systems call for a closer partnership between vendor and client

AdverseEvents, Inc., finds a receptive client base among managed-care providers

UPS acquires a temperature-controlled ground fleet, while Pelican buys Cool Logistics

Ernst & Young Firepower report sees a 'growth gap' for traditional pharmacos

J&J is the far-and-away leader in the IMS Health Social Media Engagement Index

Efforts of the National Biomarker Development Alliance will address the 'dismal' success rate of approved biomarker diagnostics

Companies are positioning themselves as approved high-volume compounders

Company's integration of Medco is 'largely complete'

Risk in other parts of the world remain higher and may be rising

Cold chain packagers balance cost, performance and compliance approaches

Today's pharma marketers have the tools to refine their communication efforts to prescribers and patients

Competitive forces sharpen as manufacturers look for the right channel partners

How new social health analytics tools are supercharging pharma's quest for patient insight

Drug Quality and Security Act's timetables for FDA, manufacturers, wholesalers, dispensers and 3PLs